In the rapidly evolving field of infectious disease diagnostics, Sansure has emerged as a trailblazer, introducing groundbreaking technologies that redefine the standards of accuracy and efficiency. One such innovation is the company’s “One-Tube Fast Release Technology,” which is revolutionizing the way healthcare professionals approach EBV screening and other critical diagnostic procedures.
One-Tube Fast Release Technology: Streamlining EBV Screening
Sansure’s “One-Tube Fast Release Technology” is the world’s leading PCR detection technology in the industry. The patented Sansure nucleic acid release technology enables rapid lysis of pathogens at room temperature without heating, centrifugation, or tube changes and rapid extraction of sample DNA/RNA by a simple operation. Therefore, the tests are not restricted to the labs alone, as medical practitioners may conduct EBV screening on many other occasions.
Keep Amplification Time Within 70 Minutes
Based on the traditional fluorescent PCR instrument, the “multiplex fluorescent PCR amplification technology” has been developed and upgraded independently in Sansure. It enables rapid and accurate identification and diagnosis of various pathogens, including the Epstein-Barr virus (EBV). As a result, the amplification time is limited to 70 minutes, allowing healthcare providers to make timely decisions and initiate appropriate treatment.
Sensitivity Reaches 400 Copies/mL
Sensitivity plays a vital role in evaluating the accuracy and reliability of a diagnostic test both prior to implementation and as part of ongoing quality assurance. EBV screening is no exception. Higher test sensitivity equates to positive infection and means a lower rate of false negative results. Under the premise of guaranteed PCR amplification reaction time, Sansure’s EBV virus DNA Quantitative Fluorescence Diagnostic Kit has a high sensitivity reaching 400 copies/mL.
Conclusion
The high specificity and sensitivity that co-exist in Sansure’s EBV virus DNA Quantitative Fluorescence Diagnostic Kit demonstrate the strengths of the company’s innovative technologies, marking it as a leading diagnostic kit solution. By combining the power of One-Tube Fast Release Technology, rapid amplification, and exceptional sensitivity, Sansure has positioned itself as a trusted partner in the fight against the Epstein-Barr virus and other infectious diseases, empowering healthcare professionals to deliver the best possible care to their patients.
